RYAMRA

Serial Number 79274312
Registration 6187268
700

Registration Progress

Application Filed
Nov 6, 2019
Under Examination
Approved for Publication
Aug 18, 2020
Published for Opposition
Aug 18, 2020
Registered
Nov 3, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20201103)
Due: Nov 03, 2026 322 days

Trademark Image

RYAMRA

Basic Information

Serial Number
79274312
Registration Number
6187268
Filing Date
November 6, 2019
Registration Date
November 3, 2020
Published for Opposition
August 18, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 3, 2020
Registration
Registered
Classes
005

Rights Holder

Idorsia Pharmaceuticals Ltd

25
Address
Hegenheimermattweg 91
CH-4123 Allschwil
CH

Ownership History

Idorsia Pharmaceuticals Ltd

Original Applicant
25
CH

Idorsia Pharmaceuticals Ltd

Owner at Publication
25
CH

Idorsia Pharmaceuticals Ltd

Original Registrant
25
CH

Legal Representation

Attorney
Mary Margaret L. O'Donnell

USPTO Deadlines

Next Deadline
322 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20201103)
Due Date
November 03, 2026
Grace Period Ends
May 03, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Nov 3, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Mar 14, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 21, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 21, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 3, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 11, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 3, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 18, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 18, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 29, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 14, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 13, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 12, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 12, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 9, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 9, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 9, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jun 9, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 9, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 9, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 21, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 5, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 5, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Feb 13, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 12, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 8, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 24, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 19, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer

Classification

International Classes
005